Co-Founder, Women’s Capital Connection; Former VP, Hallmark Cards
Board Member, Angel Capital Association; Faculty, Venture Capital Institute
Former CFO - Investments, Hillspire LLC (Eric Schmidt Family Office)
Member, Astia Investment Committee
Invested in 30+ companies
Founding Principal, Impact Seat
Investor in 5 funds; Lead in 3
ExplORer Surgical, CEO and Co-Founder
Venture Partner, Converge Venture Partners
Former Managing Director, Houston Angel Network
Healthcare Strategic Advisor and Consultant
CEO, Go Beyond Network
Prolific early stage investor
Portfolio of European and US companies
OtoSense, Portfolia’s first exit
Investor in 4 funds; Lead in 3
Founder and Former Chair and CEO, Bridgestream Software
Biotech business executive and venture capitalist; California Life Sciences Institute, Chair Emeritus
Managing Partner, Lamson Partners; Angel Investor
New York Chair, Tiger 21; Startup Advisor
Stanford University School of Medicine, Former Chair of the Department of Obstetrics and Gynecology; Yale University School of Medicine, Professor of Clinical Obstetrics and Gynecology
Founder, Makeda Capital
Managing Principal, Brickworks Advisors; Angel Investor; Co-Founder, WomenAngels
General Partner, Astarte Ventures
Partner, Catalyst Health Ventures; Healthcare and Life Sciences Executive
People often ask us how to evaluate the companies that we come across. Below are the categories we use to evaluate incoming companies, or opportunities, for potential investment. If you know of any early-stage companies that meet these qualities (or have friends that do), send them our way via our referral page. For a deeper dive, sign up to join us on our investment platform. Happy deal hunting!
One of our favorite questions to ask of our entrepreneurial start-ups is “Why Now?”
Portfolia-backed company, 4Degrees, which just secured additional funding (Congrats!), uses artificial intelligence (AI) to improve your competitive advantage when managing professional relationships. Given that Steve Levine from Axios just reported that a recent McKinsey report shows early AI adopters may gain an “insurmountable advantage” and that “companies failing to quickly embrace AI to improve growth, risk falling further and further behind” we think that’s a good idea -- and a timely one at that.
Collette Courtion, Founder and CEO of Portfolia-backed FemTech company JoyLux, shares how they're redefining women's sexual wellness in Fast Company's This Vaginal Device Pomises to Fix Women's Sex Lives. "Women are becoming far much more empowered to embrace their health in all parts of their life,” says Courtion. Joylux found that 50% of respondents reported bladder leakage issues, and when asked if they were interested in a home solution, a whopping 95% answered yes. “That tells me that it’s an underserved market,” says Courtion.
While Femtech is predicted to be a $50B industry by 2025, only 1.4% of venture capital is invested in it. Sign up to learn more about our open FemTech Fund.